STUDY PROTOCOL
Accepted on 19 Dec 2025
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Genetically Engineered T cells and Recombinant Antibodies to Target Intracellular Neoantigens: Current Status and Future Directions
Genetically Engineered T cells and Recombinant Antibodies to Target Intracellular Neoantigens: Current Status and Future Directions
1,319
Total downloads
10k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 06 Oct 2025
Effective MRD clearance and long-term survival with CD19 CAR-T in pediatric B-ALL patients with MRD positivity or chemotherapy intolerance
doi 10.3389/fimmu.2025.1672509
- 2,093 views
ORIGINAL RESEARCH
Published on 15 May 2025
Bispecific antibody targeting shared indel-derived neoantigen of APC
doi 10.3389/fimmu.2025.1574958
- 3,078 views
ORIGINAL RESEARCH
Published on 15 May 2025
Identification of shared neoantigens derived from frameshift mutations in the APC gene
doi 10.3389/fimmu.2025.1574955
- 3,243 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
T Cell Biology
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: